184
Participants
Start Date
August 31, 2009
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
pegylated interferon a-2a
180 μg, once per week s.c. for 24 weeks
Entecavir
0.5 mg once daily per os, either 72 weeks or 96 weeks
Ruijin Hospital, Shanghai
Shanghai Public Health Center, Shanghai
Zhong Shan hospital, Fu Dan University, Shanghai
Amsterdam Medical Center (AMC), Amsterdam
Erasmus Medical Center, Rotterdam
CMUMU, Bydgoszcz
Medical University, Dept of Infections Diseases, Wroclaw
WAMED, Zawiercie
Fundeni Clinical Institute, Bucharest
Nat. Institute of inf. Disease, Bucharest
University of Ankara, Medical School, Ankara
Yuksek Ihsitas Hospital, Dept. Gastroenterology, Ankara
Cerrahpasa Medical Faculty, Istanbul
Lead Sponsor
Foundation for Liver Research
OTHER